
Coronavirus disease 2019 and the natural agents: Is there a role for the primary care?
Author(s) -
Manal O Alharthi,
Raghad A. Alasmari,
Rahaf I Almatani,
Rehab M Alharthi,
Suha A Aljumaiei,
Bashayr A Alkuhayli,
Ahmed M. Kabel
Publication year - 2021
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_2195_20
Subject(s) - medicine , myalgia , intensive care medicine , disease , covid-19 , coronavirus , virus , infectious disease (medical specialty) , immunology
Coronavirus disease 2019 (COVID-19) is a newly discovered RNA virus that belongs to corona virus group. It leads to an infectious state manifested as fever, loss of smell and taste sensations, cough, myalgia, fatigue and headache. The condition may become more serious as difficulty in breathing, chest pain and even death. Until successful vaccine is developed, complimentary and herbal medicine can be used as alternative prevention measure against COVID-19 in high-risk populations. This is because the none of the traditional agents used in the treatment protocols had proven effective results. In addition, recent studies reported that dietary supplements and herbal agents may have effective antioxidant and anti-inflammatory properties that may contribute efficiently to amelioration of the effects of COVID-19. This review sheds light on the possible role of the natural agents in the management of COVID-19 with reference to the role of the primary care in this issue.